✦ LIBER ✦

Reversibility of Renal Impairment in Patients With Multiple Myeloma Treated With Bortezomib-Based Regimens: Identification of Predictive Factors

✍ Scribed by Dimopoulos, Meletios A.; Roussou, Maria; Gavriatopoulou, Maria; Zagouri, Flora; Migkou, Magdalini; Matsouka, Charis; Barbarousi, Despina; Christoulas, Dimitrios; Primenou, Erasmia; Grapsa, Irini; Terpos, Evangelos; Kastritis, Efstathios

Book ID: 119936125
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 115 KB
Volume: 9
Category: Article
ISSN: 1557-9190
DOI: 10.3816/clm.2009.n.059

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of patients with multiple myel

Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens

✍ Roussou, Maria; Kastritis, Efstathios; Migkou, Magdalini; Psimenou, Erasmia; Gra 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 555 KB

Safety and efficacy of bortezomib-based

Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA

✍ Fortunato Morabito; Massimo Gentile; Stefania Ciolli; Maria T. Petrucci; Sara Ga 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Renal impairment is not an independent a

Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens

✍ Eleftherakis-Papapiakovou, Evangelos; Kastritis, Esftathios; Roussou, Maria; Gko 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 413 KB

Outcomes of patients with multiple myelo

Outcomes of patients with multiple myeloma and renal impairment treated with bortezomib, cyclophosphamide, and dexamethasone without plasma exchange

✍ Luciano J. Costa; Jonathan Abbas; Karen L. Ortiz-Cruz; Yubin Kang; Robert K. Stu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Lymphocytopenia is associated with an in

Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens

✍ Sung-Hoon Jung, Soo-Young Bae, Jae-Sook Ahn… 📂 Article 📅 2013 🏛 Carden Jennings Publishing 🌐 English ⚖ 176 KB

Upregulated expression of the PSMB5 gene

Upregulated expression of the PSMB5 gene may contribute to drug resistance in patient with multiple myeloma when treated with bortezomib-based regimen

✍ Lü Shuqing; Yang Jianmin; Huang Chongmei; Cheng Hui; Jianmin Wang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 111 KB